Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ

$33.08

$+0.56

(+1.73%)

Regular Market

Amylyx Pharmaceuticals, Inc. (AMLX) Live Price Chart

Last updated: ⁦2026-09-21 14:21:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Amylyx Pharmaceuticals, Inc. (AMLX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $33.08, with a market capitalization of $4.14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.83 to $41.14. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4.14B
Open	$32.55
Day's High	$41.93
Day's Low	$1.58
Previous Close	$32.41
Volume	63.50K
Average Volume	2.48M
P/E Ratio	--
52-Week High	$41.14
52-Week Low	$10.83
Dividend Yield	--
Earnings Date	--

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Price Today

Amylyx Pharmaceuticals, Inc. (AMLX) is currently trading at $33.08 as of 2026-09-21 14:04:56, up 2.07% ($0.67) from the previous close of $32.41

During today's regular trading session, AMLX has traded between $1.58 and $41.93, with a trading volume of 63.50K shares. The current price is near the upper end of today's range.

Amylyx Pharmaceuticals, Inc. (AMLX) 7-Day Stock Price Change

Over the past seven days, Amylyx Pharmaceuticals, Inc. (AMLX) moved from $32.09 to $33.08, representing a gain of 3.09% ($0.99).

The stock traded between $31.37 and $34.35 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 1.75 million shares, up versus the previous seven-day period, indicating higher trading activity.

AMLX 52-Week Price Position

Position in Range: 73.4%

52W Low$10.83

52W High$41.14

AMLX is currently trading at $33.08, placing it 73.4% of the way from its 52-week low of $10.83 to its 52-week high of $41.14. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Amylyx Pharmaceuticals, Inc. (AMLX)?

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Amylyx Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	136
Exchange	NASDAQ
Company Website	https://www.amylyx.com

How to Buy Amylyx Pharmaceuticals, Inc. (AMLX) Stock on MEXC

Eligible investors can buy real shares of Amylyx Pharmaceuticals, Inc. (AMLX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AMLX and Place Your Order

Open the RealStocks trading page and search for AMLX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Amylyx Pharmaceuticals, Inc. (AMLX) stock price today?

Amylyx Pharmaceuticals, Inc. (AMLX) is currently trading at $ 33.08, up 2.07% ($0.67) from the previous close of $ 32.41. Intraday prices update in real time during regular trading hours.

2.Is AMLX stock going up or down today?

As of 2026-09-21 14:04:56, AMLX is trading at $ 33.08, up 2.07% ($0.67) from its previous close of $ 32.41. The stock has traded between $ 1.58 and $ 41.93 during today’s regular session. Past price movements do not guarantee future results.

3.What is AMLX pre-market price?

As of 2026-09-21 14:04:56, AMLX is trading at $ 32.40 in pre-market trading, down 0.03% ($0.01) from the previous close of $ 32.41. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AMLX after-hours price?

As of 2026-09-21 14:04:56, AMLX is trading at $ 33.19 in after-hours trading, up 2.39% ($0.78) from the regular-session close of $ 32.41. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AMLX stock trading now?

AMLX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AMLX sit relative to its 52-week high and low?

Over the past 52 weeks, AMLX has traded between a low of $ 10.83 and a high of $ 41.14. At $ 33.08, the stock is positioned 73.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Amylyx Pharmaceuticals, Inc. in?

Amylyx Pharmaceuticals, Inc. (AMLX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Amylyx Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Amylyx Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 4.14B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AMLX valued in terms of P/E ratio and EPS?

AMLX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.19. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Amylyx Pharmaceuticals, Inc. pay a dividend?

Amylyx Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.